XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Jan. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
Note 17—Income Taxes
The components of income (loss) before income taxes are as follows:
 
    
2023
    
2022
    
2021
 
(In thousands)                     
Domestic
   $ 1,773      $ 5,046      $ (1,193
Foreign
     1,637        1,988        3,372  
    
 
 
    
 
 
    
 
 
 
     $ 3,410      $ 7,034      $ 2,179  
    
 
 
    
 
 
    
 
 
 
 
The components of the provision for income taxes are as follows:
 
 
  
2023
 
  
2022
 
  
2021
 
(In thousands)
  
 
 
  
 
 
  
 
 
Current:
                          
Federal
   $ 902      $ (183    $ 1,272  
State
     313        76        224  
Foreign
     870        501        420  
    
 
 
    
 
 
    
 
 
 
       2,085        394        1,916  
    
 
 
    
 
 
    
 
 
 
Deferred:
                          
Federal
   $ (1,053    $ 180      $ (910
State
     (315      177        (189
Foreign
     32        (146      78  
    
 
 
    
 
 
    
 
 
 
       (1,336      211        (1,021
    
 
 
    
 
 
    
 
 
 
     $ 749      $ 605      $ 895  
    
 
 
    
 
 
    
 
 
 
Total income tax provision differs from the expected tax provision as a result of the following:
 
    
2023
    
2022
    
2021
 
(In thousands)                     
Income Tax Provision at Statutory Rate
   $ 716      $ 1,477      $ 458  
Change in Valuation Allowance
     182        57        (81
Foreign Rate Differential
     157        61        197  
Change in Reserves Related to ASC 740 Liability
     93        (245      (10
Denmark Statutory Audit
     —          —          341  
Meals and Entertainment
     —          9        11  
Canada Withholding Taxes
     —          —          62  
Global Intangible Low Taxed Income
     —          —          14  
Foreign Derived Intangible Income
     (180      (55      (150
R&D Credits
     (160      (180      (157
Share Based Compensation
     (52      (95      171  
Return to Provision Adjustment
     (22      368        (2
State Taxes, Net of Federal Tax Effect
     (2      143        28  
PPP Loan Forgiveness
     —          (937      —    
Other
     17        2        13  
    
 
 
    
 
 
    
 
 
 
     $ 749      $ 605      $ 895  
    
 
 
    
 
 
    
 
 
 
Our effective tax rate for fiscal 2023 was 22.0% compared to 8.6% in fiscal 2022 and 41.1% in fiscal 2021. The increase in the effective tax rate in fiscal 2023 from fiscal 2022 is primarily related to the absence of the PPP loan forgiveness which is
tax-exempt
income that was a
one-time
item that reduced the rate in fiscal 2022. Specific items increasing the effective tax rate in fiscal 2023 include the change in reserves related to ASC 740 liability and the increase in the valuation allowance recorded on China net operating losses. This increase was offset by state taxes, return to provision adjustments, share-based compensation, R&D tax credits, and foreign derived intangible income (“FDII”) deduction.
The decrease in the effective tax rate in fiscal 2022 from fiscal 2021 is primarily related to the
one-time
impact of the PPP loan forgiveness
tax-exempt
income. Specific items decreasing the effective tax rate include PPP loan forgiveness
tax-exempt
income, R&D tax credits, foreign derived intangible income (“FDII”) deduction and change in reserves related to ASC 740 liabilities. This decrease was offset by state taxes, return to provision adjustments, and taxes on foreign earnings.
 
The components of deferred income tax expense arise from various temporary differences and relate to items included in the statement of income. The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets and liabilities are as follows:
 
    
January 31,
 
(In thousands)

  
2023
    
2022
 
Deferred Tax Assets:
                 
Inventory
   $ 2,710      $ 2,159  
Honeywell Royalty Liability
     3,008        2,655  
State R&D Credits
     1,851        1,925  
Share-Based Compensation
     620        593  
Bad Debt
     180        213  
Warranty Reserve
     258        198  
Compensation Accrual
     248        322  
Net Operating Loss
     135        152  
ASU 842 Adjustment – Lease Liability
     53        93  
Unrecognized State Tax Benefits
     58        64  
Foreign Tax Credit
     154        154  
Deferred Service Contract Revenue
     90        61  
Section 174 Capitalization*
     1,175        —    
Other
     281        224  
    
 
 
    
 
 
 
     10,821      8,813  
Deferred Tax Liabilities:
                 
Accumulated Tax Depreciation in Excess of Book Depreciation
     1,037        455  
Intangibles
     694        767  
ASU 842 Adjustment – Lease Liability
     50        90  
Other
     180        318  
    
 
 
    
 
 
 
     1,961      1,630  
    
 
 
    
 
 
 
Subtotal
     8,860        7,183  
Valuation Allowance
     (2,120      (1,778
    
 
 
    
 
 
 
Net Deferred Tax Assets
   $ 6,740      $ 5,405  
    
 
 
    
 
 
 
 
*
Beginning in fiscal 2023, changes to Section 174 of the Internal Revenue Code made by the Tax Cuts and Jobs Act of 2017 no longer permit an immediate deduction for research and development expenditures in the tax year that such costs are incurred. These costs are capitalized resulting in an increase in deferred tax assets of $1.2 million.
Deferred taxes are reflected in the consolidated balance sheet as follows:
 
    
January 31,
 
    
2023
    
2022
 
Deferred Tax Assets
     6,907        5,591  
Deferred Tax Liabilities
     (167      (186
    
 
 
    
 
 
 
Total Net Deferred Tax Assets
   $ 6,740      $ 5,405  
    
 
 
    
 
 
 
The valuation allowances of $2.1 million at January 31, 2023 and $1.8 million at January 31, 2022, relate to Rhode Island research and development tax credit carryforwards, foreign tax credit carryforwards, and China’s net operating losses that are expected to expire unutilized.
 
At January 31, 2023, we had net operating loss carryforwards of $0.1 million in China, which expire in 2024 through 2028. We have net operating loss carryforwards of less than $0.1 million in France, which can be carried forward indefinitely. We expect to utilize the net operating loss carryforwards in France before in future tax periods.
At January 31, 2023, we had state research credit carryforwards of approximately $1.9 million which expire in 2023 through 2030. Additionally, we had $0.2 million of foreign tax credits. We maintain a full valuation allowance against these credits as we expect these credits to expire unused.
We believe that it is reasonably possible that some unrecognized tax benefits, accrued interest and penalties could decrease income tax expense in the next year due to either the review of previously filed tax returns or the expiration of certain statutes of limitation. The changes in the balances of unrecognized tax benefits, excluding interest and penalties are as follows:
 
    
2023
    
2022
    
2021
 
(In thousands)                     
Balance, beginning of the year
   $ 303      $ 384      $ 362  
Increases in prior period tax positions
     24        63        59  
Increases in current period tax positions
     136        67        5  
Reductions related to lapse of statutes of limitations
     (49      (211      (42
    
 
 
    
 
 
    
 
 
 
Balance, end of the year
   $ 414      $ 303      $ 384  
    
 
 
    
 
 
    
 
 
 
During fiscal 2023 and 2022, we released $49,000 and $211,000, respectively, of uncertain tax positions including accrued interest and penalties relating to a change in various unrecognized tax positions. The Company has accrued potential interest and penalties of $77,000 included in income taxes payable in the accompanying consolidated balance sheet at the end of January 31, 2023.
The Company and its subsidiaries file income tax returns in U.S. federal jurisdictions, various state jurisdictions, and various foreign jurisdictions. In fiscal 2023, we released $27,000 related to a federal tax exposure for the fiscal 2019 tax year and $22,000 of state nexus positions as a result of the expiration of the statute of limitations.
U.S. income taxes have not been provided on $8.5 million of undistributed earnings of our foreign subsidiaries since it is our intention to permanently reinvest such earnings offshore. If the earnings were distributed in the form of dividends, the Company would not be subject to U.S. tax as a result of the Tax Act but could be subject to foreign income and withholding taxes. Determination of the amount of this unrecognized deferred income tax liability is not practical.